Update on Berberine in Nonalcoholic Fatty Liver Disease
Improving the ameliorative effects of berberine and curcumin combination via dextran-coated bilosomes on non-alcohol fatty liver disease in mice | Journal of Nanobiotechnology | Full Text
Molecules | Free Full-Text | The Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease
Anti-inflammatory activity of berberine in non-alcoholic fatty liver disease via the Angptl2 pathway | BMC Immunology | Full Text
Berberine ameliorates methotrexate-induced liver injury by activating Nrf2/HO-1 pathway and PPARγ, and suppressing oxidative stress and apoptosis in rats - ScienceDirect
Cells | Free Full-Text | Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways
Synergy Effects of Metformin and Berberine on Glyoxal-induced Carbonyl Stress in Isolated Rat Liver Mitochondria | Bentham Science